Drug interactions
Terbutaline + Tranylcypromine
Severity: Major
Terbutaline and Tranylcypromine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Tranylcypromine is an irreversible MAO inhibitor, and terbutaline labeling warns that its cardiovascular effects may be potentiated during and shortly after MAOI use. Tachycardia, palpitations and blood pressure changes may occur.
What this interaction means in plain words
Terbutaline and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Terbutaline belongs to Respiratory; Tranylcypromine belongs to Central Nervous System.
Why it happens
MAO inhibition may potentiate vascular and cardiac effects of beta-agonists.
What to do
Avoid terbutaline within 14 days of MAOI therapy where possible; otherwise monitor heart rate and blood pressure closely.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Terbutaline and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Terbutaline
Other interactions of Tranylcypromine
- 5-HTP + Tranylcypromine Contraindicated
- Amitriptyline + Tranylcypromine Contraindicated
- Amoxapine + Tranylcypromine Contraindicated
- Atomoxetine + Tranylcypromine Contraindicated
- Benzphetamine + Tranylcypromine Contraindicated
- Brimonidine + Tranylcypromine Contraindicated
Frequently asked questions
Can I take Terbutaline with Tranylcypromine?
MediHelp rates the interaction as major. Terbutaline and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tranylcypromine is an irreversible MAO inhibitor, and terbutaline labeling warns that its cardiovascular effects may be potentiated during and shortly after MAOI use. Tachycardia, palpitations and blood pressure changes may occur.
How serious is the interaction between Terbutaline and Tranylcypromine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid terbutaline within 14 days of MAOI therapy where possible; otherwise monitor heart rate and blood pressure closely.
What other medicines interact with Terbutaline?
MediHelp also lists interactions of Terbutaline with, for example, Carvedilol, Droperidol, Fexinidazole. The full list is on the Terbutaline page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
